Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions.
作者信息
Ljubimova Julia Y, Holler Eggehard, Black Keith L, Ljubimov Alexander V
机构信息
Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
Institut für Biophysik und Physikalische Biochemie Universtität, Regensburg, D-93040, Regensburg, Germany.
出版信息
Nanomedicine (Lond). 2024;19(23):1863-1866. doi: 10.1080/17435889.2024.2380241. Epub 2024 Aug 7.
Abstract
摘要
相似文献
1
Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions.穿越血脑屏障的纳米颗粒需要针对正常、神经退行性或癌性脑疾病的特定设计。
Nanomedicine (Lond). 2024;19(23):1863-1866. doi: 10.1080/17435889.2024.2380241. Epub 2024 Aug 7.
2
Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.用于血脑屏障传递的聚合物纳米粒子的开发——策略和挑战。
Adv Sci (Weinh). 2021 Mar 7;8(10):2003937. doi: 10.1002/advs.202003937. eCollection 2021 May.
3
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration.推进神经疾病治疗：有机纳米颗粒作为突破血脑屏障的关键
Int J Pharm. 2025 Feb 10;670:125186. doi: 10.1016/j.ijpharm.2025.125186. Epub 2025 Jan 7.
4
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?用于靶向脑内药物递送的纳米颗粒：我们了解多少？
Int J Mol Sci. 2021 Oct 28;22(21):11654. doi: 10.3390/ijms222111654.
5
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.脂质纳米载体辅助递药治疗神经退行性疾病的最新研究进展。
Eur J Pharm Biopharm. 2020 Apr;149:192-217. doi: 10.1016/j.ejpb.2020.01.005. Epub 2020 Jan 23.
6
Overcoming the blood-brain barrier in neurodegenerative disorders and brain tumours.克服神经退行性疾病和脑肿瘤的血脑屏障。
IET Nanobiotechnol. 2020 Aug;14(6):441-448. doi: 10.1049/iet-nbt.2019.0351.
7
Blood-Brain Barrier and Neurodegenerative Diseases-Modeling with iPSC-Derived Brain Cells.血脑屏障与神经退行性疾病——iPSC 衍生脑细胞模型研究。
Int J Mol Sci. 2021 Jul 19;22(14):7710. doi: 10.3390/ijms22147710.
8
Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.用于脑癌治疗学的新兴血脑屏障穿透纳米技术。
Chem Soc Rev. 2019 Jun 4;48(11):2967-3014. doi: 10.1039/c8cs00805a.
9
Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.中枢神经系统癌症的细胞和分子靶向药物递送：靶向策略的进展。
Curr Top Med Chem. 2020;20(30):2762-2776. doi: 10.2174/1568026620666200826122402.
10
Noninvasive nanoparticle strategies for brain tumor targeting.用于脑肿瘤靶向的非侵入性纳米颗粒策略。
Nanomedicine. 2017 Nov;13(8):2605-2621. doi: 10.1016/j.nano.2017.07.009. Epub 2017 Jul 27.
引用本文的文献
1
Precision Neuro-Oncology in Glioblastoma: AI-Guided CRISPR Editing and Real-Time Multi-Omics for Genomic Brain Surgery.胶质母细胞瘤中的精准神经肿瘤学：用于基因组脑手术的人工智能引导的CRISPR编辑和实时多组学技术
Int J Mol Sci. 2025 Jul 30;26(15):7364. doi: 10.3390/ijms26157364.
2
Antibody-Free Immunopeptide Nano-Conjugates for Brain-Targeted Drug Delivery in Glioblastoma Multiforme.用于多形性胶质母细胞瘤脑靶向给药的无抗体免疫肽纳米缀合物
bioRxiv. 2025 Mar 12:2025.03.07.641755. doi: 10.1101/2025.03.07.641755.
3
Blood-brain barrier crossing biopolymer targeting c-Myc and anti-PD-1 activate primary brain lymphoma immunity: Artificial intelligence analysis.穿越血脑屏障的生物聚合物靶向c-Myc和抗PD-1激活原发性脑淋巴瘤免疫：人工智能分析
J Control Release. 2025 May 10;381:113611. doi: 10.1016/j.jconrel.2025.113611. Epub 2025 Mar 13.
4
The potential of nanoparticle-based contrast agents in the diagnosis of neurodegenerative pathologies.基于纳米颗粒的造影剂在神经退行性疾病诊断中的潜力。
Nanomedicine (Lond). 2025 Feb;20(3):247-249. doi: 10.1080/17435889.2024.2428588. Epub 2024 Nov 14.
本文引用的文献
1
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy.糖尿病性视网膜病变是一种神经酰胺病，可通过抗神经酰胺免疫疗法逆转。
Cell Metab. 2024 Jul 2;36(7):1521-1533.e5. doi: 10.1016/j.cmet.2024.04.013. Epub 2024 May 7.
2
Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions.DAT SPECT成像在诊断路易体痴呆中的实际应用：美国对现行指南及未来方向的观点
Front Neurol. 2024 Apr 22;15:1395413. doi: 10.3389/fneur.2024.1395413. eCollection 2024.
3
Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.多模态神经纳米技术：挑战胶质母细胞瘤治疗的现有范式。
Proc Natl Acad Sci U S A. 2024 Feb 20;121(8):e2306973121. doi: 10.1073/pnas.2306973121. Epub 2024 Feb 12.
4
Designing drugs optimized for both blood-brain barrier permeation and intra-cerebral partition.设计既能优化血脑屏障通透性又能优化脑内分布的药物。
Expert Opin Drug Discov. 2024 Mar;19(3):317-329. doi: 10.1080/17460441.2023.2294118. Epub 2023 Dec 25.
5
A Comprehensive Study on Nanoparticle Drug Delivery to the Brain: Application of Machine Learning Techniques.纳米颗粒药物递送至大脑的综合研究：机器学习技术的应用
Mol Pharm. 2024 Jan 1;21(1):333-345. doi: 10.1021/acs.molpharmaceut.3c00880. Epub 2023 Dec 7.
6
β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models.β-淀粉样蛋白靶向纳米药物用于阿尔茨海默病小鼠模型中神经元特异性的核酸递送。
J Control Release. 2023 Sep;361:636-658. doi: 10.1016/j.jconrel.2023.08.001. Epub 2023 Aug 17.
7
The blood-brain barrier: structure, regulation, and drug delivery.血脑屏障：结构、调控与药物递送。
Signal Transduct Target Ther. 2023 May 25;8(1):217. doi: 10.1038/s41392-023-01481-w.
8
Improved prediction and characterization of blood-brain barrier penetrating peptides using estimated propensity scores of dipeptides.使用二肽的预测倾向评分提高血脑屏障穿透肽的预测和表征。
J Comput Aided Mol Des. 2022 Nov;36(11):781-796. doi: 10.1007/s10822-022-00476-z. Epub 2022 Oct 26.
9
Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer's, and Tumor Mouse Models.载体引导的系统纳米生物缀合物经血脑屏障递送至正常、阿尔茨海默病和肿瘤小鼠模型的特征效应。
ACS Nano. 2022 Aug 23;16(8):11815-11832. doi: 10.1021/acsnano.1c10034. Epub 2022 Aug 12.
10
Multifunctional Nanopolymers for Blood-Brain Barrier Delivery and Inhibition of Glioblastoma Growth through EGFR/EGFRvIII, c-Myc, and PD-1.用于血脑屏障递送及通过表皮生长因子受体/表皮生长因子受体变异体III、c-Myc和程序性死亡受体1抑制胶质母细胞瘤生长的多功能纳米聚合物
Nanomaterials (Basel). 2021 Oct 28;11(11):2892. doi: 10.3390/nano11112892.
Zotero 插件